Atlas Trials

A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome

Clinical trial NCT00001839 · COMPLETED

Trial details

NCT number
NCT00001839
Sponsor
National Institutes of Health Clinical Center (CC)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hematologic DiseasesMyelodysplastic Syndromes
Start date
1998-12-01
Enrollment
182

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.